ProFunds Biotechnology UltraSector Fund Investor Class

Frequently Asked Questions About BIPIX

What does BIPIX invest in?

This fund's primary objective is to generate daily investment returns that are one and a half times (1.5x) the daily movement of the Dow Jones U.S. BiotechnologySM Index, before any deductions for fees and expenses. To achieve this leveraged daily exposure, the fund strategically allocates its assets to various financial instruments that the adviser expects will produce results aligned with its specific investment goal. The aforementioned index serves as a benchmark, monitoring the performance of select companies within the biotechnology sector of the American stock market. It is important to note that this fund is not diversified, indicating a concentrated investment strategy.

What is the expense ratio of BIPIX?

ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) charges an expense ratio of 1.52%. This is the annual fee deducted from fund assets to cover management and operations.

How big is BIPIX?

ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) manages $352.0M in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.

Is BIPIX actively managed or an index fund?

BIPIX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.

When was BIPIX launched?

ProFunds Biotechnology UltraSector Fund Investor Class (BIPIX) launched in June 2000 and is managed by the fund issuer.

How has BIPIX performed?

BIPIX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.